New Products In Brief
This article was originally published in The Tan Sheet
Executive Summary
Symbollon takes supplement route: IoGen launches as a dietary supplement for women's breast health after Symbollon Pharmaceuticals' application with FDA seeking medical food approval stalled, said a spokeswoman for the Medfield, Mass., biotech firm. Symbollon completed eight clinical trials evaluating the effects of its molecular iodine compound on mastalgia and fibrosis in more than 2,000 patients. Starting in February, IoGen will be available in health food stores, online and through gynecologists, at a suggested retail price of $29.99 for 30 tablets